Literature DB >> 15242639

Huntington's disease: new paths to pathogenesis.

Christopher A Ross1.   

Abstract

Huntington's disease is a progressive autosomal dominant neurodegenerative disorder caused by expansion of a CAG repeat coding for polyglutamine in the huntingtin protein. A recent report suggests a new mechanism involving altered interactions with a protein involved in axonal transport, leading to loss of neurotrophic factor transport. This suggests an intriguing convergence to previously described pathways implicating neurotrophin transcription in HD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15242639     DOI: 10.1016/j.cell.2004.06.022

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  18 in total

Review 1.  The elimination of accumulated and aggregated proteins: a role for aggrephagy in neurodegeneration.

Authors:  Ai Yamamoto; Anne Simonsen
Journal:  Neurobiol Dis       Date:  2010-08-20       Impact factor: 5.996

2.  Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease.

Authors:  Paula A Desplats; James R Lambert; Elizabeth A Thomas
Journal:  Neurobiol Dis       Date:  2008-05-22       Impact factor: 5.996

3.  Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice.

Authors:  Edgardo Rodriguez-Lebron; Eileen M Denovan-Wright; Kevin Nash; Alfred S Lewin; Ronald J Mandel
Journal:  Mol Ther       Date:  2005-10       Impact factor: 11.454

Review 4.  Progress in developing transgenic monkey model for Huntington's disease.

Authors:  Brooke R Snyder; Anthony W S Chan
Journal:  J Neural Transm (Vienna)       Date:  2017-11-10       Impact factor: 3.575

5.  The University of Washington Health Sciences Library BioCommons: an evolving Northwest biomedical research information support infrastructure.

Authors:  Mark Minie; Stuart Bowers; Peter Tarczy-Hornoch; Edward Roberts; Rose A James; Neil Rambo; Sherrilynne Fuller
Journal:  J Med Libr Assoc       Date:  2006-07

Review 6.  Mutant huntingtin and mitochondrial dysfunction.

Authors:  Ella Bossy-Wetzel; Alejandra Petrilli; Andrew B Knott
Journal:  Trends Neurosci       Date:  2008-10-24       Impact factor: 13.837

7.  Mutant huntingtin alters cell fate in response to microtubule depolymerization via the GEF-H1-RhoA-ERK pathway.

Authors:  Hemant Varma; Ai Yamamoto; Melissa R Sarantos; Robert E Hughes; Brent R Stockwell
Journal:  J Biol Chem       Date:  2010-09-21       Impact factor: 5.157

8.  Phosphorylation of huntingtin by cyclin-dependent kinase 5 is induced by DNA damage and regulates wild-type and mutant huntingtin toxicity in neurons.

Authors:  Sandrine L Anne; Frédéric Saudou; Sandrine Humbert
Journal:  J Neurosci       Date:  2007-07-04       Impact factor: 6.167

9.  Prion protein with an octapeptide insertion has impaired neuroprotective activity in transgenic mice.

Authors:  Aimin Li; Pedro Piccardo; Sami J Barmada; Bernardino Ghetti; David A Harris
Journal:  EMBO J       Date:  2007-05-17       Impact factor: 11.598

Review 10.  Ageing and neuronal vulnerability.

Authors:  Mark P Mattson; Tim Magnus
Journal:  Nat Rev Neurosci       Date:  2006-04       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.